2 unknown, 1 terminated, 1 withdrawn. 2 Phase 3, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Unknown 1, Withdrawn 1 |
| Phase 1 | 1 | Unknown 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Intravenous immunoglobulin therapy: new trials by email Literature Review of Intravenous immunoglobulin therapy trials Research Report on Intravenous immunoglobulin therapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Participants With Guillain-Barré Syndrome (GBS) Crovalimab, Placebo, Intravenous immunoglobulin therapy - Guillain-Barré Syndrome | Phase 3 | Withdrawn | Hoffmann-La Roche | 2022-11-30 | 2022-12-15 | |
| Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis Infliximab, Intravenous Immunoglobulin Therapy, Prednisone - Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm | Phase 2 | Terminated | ECOG-ACRIN Cancer Research Group | 1 | 2021-01-07 | 2026-09-29 |
| Intravenous Immunoglobulins for the Treatment of Covid-19 Patients: a Clinical Trial intravenous immunoglobulin therapy - Covid19 | Phase 3 | Unknown | University of Health Sciences Lahore | 60 | 2020-09-15 | 2020-09-14 |
| IVIg Therapy for Patients With Idiopathic Cardiomyopathy and Endomyocardial Biopsy Proven High PVB19 Viral Load Intravenous immunoglobulin therapy - Heart Failure | Phase 1 | Unknown | Maastricht University Medical Center | 40 | 2009-02-01 | 2009-02-04 |
COVID-19 (1) · Guillain-Barre Syndrome (1) · Heart Failure (1) · Hematologic Neoplasms (1)
ECOG-ACRIN Cancer Research Group (1) · Hoffmann-La Roche (1) · Maastricht University Medical Center (1) · University of Health Sciences Lahore (1)
Netherlands (1) · Pakistan (1) · United States (1)
Fridoon J Ahmad, Ph.D (1) · Jarushka Naidoo (1) · Javed Akram, MBBS,FRCP,MRCP (1) · Stephane Heymans, MD, PhD (1)
UG1CA189828 (1)